Aquestive Therapeutics (AQST) PT Raised to $12 at H.C. Wainwright

Go back to Aquestive Therapeutics (AQST) PT Raised to $12 at H.C. Wainwright

Aquestive Therapeutics (AQST) PT Lowered to $23 at JMP Securities

July 16, 2019 3:13 AM EDT

JMP Securities analyst Jason Butler lowered the price target on Aquestive Therapeutics (NASDAQ: AQST) to $23.00 (from $25.00) while maintaining a Market Outperform rating.

... More